Centro Médico Teknon
Centro Médico Teknon
Spain, Barcelona
Jaume Capdevila
26 years of experience
accreditations :
Clinic is certified :
Immunotherapy in Spain typically costs from $12,000 to $25,000. The final price depends on the drug protocol, cancer type, and number of treatment cycles required. Patients save around 38% compared to the US, where the average cost is $30,000. Most Spanish clinics bundle specialist consultations, diagnostic tests, and medication administration into the total price.
Bookimed Expert Insight: Spain offers a unique high-value entry point for experimental oncology. Patients at Quironsalud Madrid may access cutting-edge immunodrugs for free via clinical trials. Specialized centers like SJD Barcelona Children’s Hospital use in-house molecular labs to refine treatment. This reduces waste on ineffective drugs. Clinics like Centro Médico Teknon provide JCI-accredited care while hosting world-renowned specialists at competitive European rates.
Why choose Spain for immunotherapy?
Access advanced Immunotherapy solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Immunotherapy | from $2,200 | from $30,000 | from $12,000 |
| Sarcoma Immunotherapy | from $18,000 | from $60,000 | from $80,000 |
| Immunotherapy for prostate cancer | from $12,000 | from $30,000 | from $35,000 |
| Immunotherapy for lung cancer | from $18,000 | from $30,000 | from $30,000 |
| Immunotherapy for breast cancer | from $9,500 | from $35,000 | from $45,000 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy upon arrival and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy journey.
Dr. Graupera heads the Hematology Oncology Department at Sant Joan De Déu – one of Europe's top children's hospitals. His research focuses on pediatric cancer treatments.
Dr. Graus defined the first strict diagnostic criteria for paraneoplastic neurological syndromes – a key breakthrough in immunotherapy-related neurotoxicity.
Leader in immunotherapy research for melanoma and breast cancer – Dr. Soberino has contributed to groundbreaking drug approvals that revolutionized treatment.
World-renowned leader in Chronic Lymphocytic Leukemia (CLL) – Professor Bosch leads over 80 clinical trials on new treatments.
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
Written by Kateryna Zamkovska
When considering Immunotherapy, it’s important to understand the different techniques and which is best suited for you. Here’s a concise comparison of popular options:
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.
CAR T-cell therapy is a personalized immune system therapy that modifies a patient's T-cells to target and destroy cancer cells.